SI-BONE, Inc. (NASDAQ:SIBN) Stock Position Lifted by Silvercrest Asset Management Group LLC

Silvercrest Asset Management Group LLC grew its position in shares of SI-BONE, Inc. (NASDAQ:SIBN) by 13.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,060,937 shares of the company’s stock after buying an additional 128,702 shares during the period. Silvercrest Asset Management Group LLC owned about 2.57% of SI-BONE worth $17,368,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Brown Advisory Inc. boosted its stake in shares of SI-BONE by 5.4% during the 4th quarter. Brown Advisory Inc. now owns 4,207,703 shares of the company’s stock worth $88,320,000 after acquiring an additional 214,089 shares in the last quarter. First Light Asset Management LLC raised its holdings in SI-BONE by 0.9% during the fourth quarter. First Light Asset Management LLC now owns 2,547,392 shares of the company’s stock valued at $53,470,000 after buying an additional 23,299 shares in the last quarter. Vanguard Group Inc. grew its position in SI-BONE by 1.8% during the first quarter. Vanguard Group Inc. now owns 2,463,501 shares of the company’s stock worth $40,328,000 after buying an additional 43,670 shares in the last quarter. Champlain Investment Partners LLC boosted its holdings in SI-BONE by 104.8% during the first quarter. Champlain Investment Partners LLC now owns 2,453,147 shares of the company’s stock valued at $40,158,000 after purchasing an additional 1,255,610 shares in the last quarter. Finally, Granahan Investment Management LLC boosted its holdings in SI-BONE by 13.2% during the fourth quarter. Granahan Investment Management LLC now owns 1,286,450 shares of the company’s stock valued at $27,003,000 after purchasing an additional 150,217 shares in the last quarter. Institutional investors own 98.11% of the company’s stock.

SI-BONE Trading Up 0.1 %

SIBN stock traded up $0.01 during trading on Tuesday, hitting $15.14. The company had a trading volume of 134,313 shares, compared to its average volume of 401,700. The company has a quick ratio of 8.75, a current ratio of 9.76 and a debt-to-equity ratio of 0.22. The firm has a 50-day moving average price of $13.93 and a 200-day moving average price of $16.09. SI-BONE, Inc. has a 12 month low of $11.76 and a 12 month high of $26.03. The stock has a market cap of $623.92 million, a price-to-earnings ratio of -13.88 and a beta of 1.20.

SI-BONE (NASDAQ:SIBN) last posted its quarterly earnings data on Monday, May 6th. The company reported ($0.27) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.02. The firm had revenue of $37.87 million during the quarter, compared to analysts’ expectations of $36.45 million. SI-BONE had a negative net margin of 29.93% and a negative return on equity of 25.14%. As a group, analysts predict that SI-BONE, Inc. will post -0.95 earnings per share for the current year.

Insider Transactions at SI-BONE

In other news, insider Anthony J. Recupero sold 3,309 shares of the firm’s stock in a transaction on Tuesday, July 2nd. The stock was sold at an average price of $12.92, for a total value of $42,752.28. Following the transaction, the insider now directly owns 243,629 shares in the company, valued at approximately $3,147,686.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO Anshul Maheshwari sold 2,441 shares of the firm’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $15.14, for a total transaction of $36,956.74. Following the sale, the chief financial officer now owns 204,241 shares of the company’s stock, valued at approximately $3,092,208.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Anthony J. Recupero sold 3,309 shares of SI-BONE stock in a transaction dated Tuesday, July 2nd. The shares were sold at an average price of $12.92, for a total value of $42,752.28. Following the completion of the sale, the insider now directly owns 243,629 shares in the company, valued at approximately $3,147,686.68. The disclosure for this sale can be found here. Insiders have sold 11,956 shares of company stock worth $172,555 in the last three months. Insiders own 5.40% of the company’s stock.

Wall Street Analysts Forecast Growth

SIBN has been the topic of a number of recent research reports. JMP Securities reaffirmed a “market outperform” rating and set a $32.00 price objective on shares of SI-BONE in a report on Tuesday, May 7th. Needham & Company LLC reissued a “buy” rating and issued a $27.00 target price on shares of SI-BONE in a report on Tuesday, May 7th. Finally, Morgan Stanley reduced their target price on SI-BONE from $25.00 to $21.00 and set an “overweight” rating on the stock in a report on Monday, July 15th. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat, SI-BONE has a consensus rating of “Buy” and a consensus price target of $25.67.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.